Congress at a Glance
Scientific Programme
Satellite Programme
Maps of the Venue
Search in:
 Papers, Programme or All
 Please use only plain characters
 (e.g., e, o, c and not è, ö or ç)
 		 
   
  Author   or    Free text  
   
  Author list  

  Personal Planner:
  Create a new login and password click here
Nb. Only your Personal Planner login is valid!
  Username Password  
   
 
  


Track:
  Treatment track
  Clinical research track
  Interface track
  Preclinical track
  Educational updates track

 
Scientific Programme Track:
View last minute changes Last minute changes
Back to overview
09:00-11:05 , Sunday, 31 August 2008
Symposia   

09:00-11:05
S.01:    Treatment track
Antipsychotics beyond dopamine antagonism
Chairs:  Dieter Naber, Germany
  Joseph Peuskens, Belgium
Auditorium

09:00
S.01.01  Are metabotropic glutamate receptors new targets for antipsychotics?  Paper: S.01.01
Bruce J. Kinon, USA
 

09:25
S.01.02  Coupling/uncoupling of monoaminergic systems in psychopathology: interactions with nicotine  Paper: S.01.02
Jean-Pol Tassin, France
 

09:50
S.01.03  Dopamine partial agonists – do they live up to their expectations?  Paper: S.01.03
Gerhard Gründer, Germany
 

10:15
S.01.04  Histamine and schizophrenia: basis for drug development?
Jean-Michel Arrang, France
 

10:40
S.01.05  What are the advantages of new formulations of antipsychotic drugs?  Paper: S.01.05
Luca Pani, Italy
 

09:00-11:05
S.02:    Clinical research track
Prediction and prevention of suicide
Chairs:  Zoltán Rihmer, Hungary
  Pilar A. Saiz, Spain
Room J

09:00
S.02.01  Molecular genetic findings in suicide: what lies beyond the serotonergic system?  Paper: S.02.01
Andreas Reif, Germany
 

09:25
S.02.02  Gene-environment interactions and suicidal behaviour  Paper: S.02.02
Alain Malafosse, Switzerland
 

09:50
S.02.03  Predictive models of suicidal behaviour in mood disorders  Paper: S.02.03
J. John Mann, USA
 

10:15
S.02.04  Suicide prevention in bipolar disorder: a reality?  Paper: S.02.04
Erkki T. Isometsä, Finland
 

10:40
S.02.05  Predictors of suicide in adolescents  Paper: S.02.05
Alan Apter, Israel
 

09:00-11:05
S.03:    Interface track
Hypocretin (orexin) peptides: common currency in addiction and arousal?
Chairs:  Christian Broberger, Sweden
  Florence Noble, France
Room M

09:00
S.03.01  The neurobiology of hypocretins/orexins in narcolepsy and arousal  Paper: S.03.01
Luis de Lecea, USA
 

09:25
S.03.02  Promotion of sleep through an orally available hypocretin/orexin antagonist in rats, dogs and humans  Paper: S.03.02
François Jenck, Switzerland
 

09:50
S.03.03  Hypocretin/orexin modulation of sleep correlates in cortical network activity  Paper: S.03.03
Christian Broberger, Sweden
 

10:15
S.03.04  Metabolic state regulation of hypocretin/orexin neurones: mechanisms and implications for feeding behaviour  Paper: S.03.04
Denis Burdakov, United Kingdom
 

10:40
S.03.05  Hypocretin/orexin in addiction: a mediator of stress-induced reinstatement of cocaine-seeking behaviour  Paper: S.03.05
Benjamin Boutrel, Switzerland
 

09:00-11:05
S.04:    Preclinical track
Hot Topics 1
Chairs:  Eberhard Fuchs, Germany
  Jan M. van Ree, The Netherlands
Room F

09:00
S.04.01  Striatal synaptic and cortical nuclear orphan G protein-coupled receptor GPR88, a promising target for psychiatric and movement disorders  Paper: S.04.01
Renaud Massart, France
 

09:15
S.04.02  Imidazoline2 (I2) binding site ligands increase Fos-like immunoreactivity in the naïve and restraint-stressed rat brain  Paper: S.04.02
Karen Smith, Ireland
 

09:30
S.04.03  Exposure to an open-field induces c-Fos in a distributed anxiety-related system projecting to the basolateral amygdala  Paper: S.04.03
Matthew Hale, United Kingdom
 

09:45
S.04.04  The genetic basis of individual vulnerability to chronic stress: role of AMPA receptors  Paper: S.04.04
Mathias Schmidt, Germany
 

10:00
S.04.05  Effects of repeated treatment of phencyclidine in cognition, emotional activity and gene expression in C57BL/6J mice  Paper: S.04.05
Simret Beraki, Sweden
 

10:15
S.04.06  A role for the opioid system in endocannabinoid-mediated fear-conditioned analgesia in rats  Paper: S.04.06
Ryan Butler, Ireland
 

10:30
S.04.07  Could nicotine potentiate the beneficial effects of levodopa in the 6-OHDA rat model? A behavioural study  Paper: S.04.07
Jean-Philippe Guilloux, France
 

10:45
S.04.08  Adolescent cannabinoid exposure induces sex dependent alterations in adulthood: behavioural and biochemical evidences  Paper: S.04.08
Natalia Realini, Italy
 

Scientific café